In March 2026, medical device manufacturers increasingly adopted multi-origin sourcing strategies to mitigate geopolitical, tariff, and logistics risks.
This includes:
The shift is driven by growing supply chain vulnerability and global trade pressures, as medical devices rely on components sourced across multiple regions and tiers.